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s 13 (2014) 612Journal of Cystic FibrosiNewsMedian age of survival continues to increase. A survival
analysis of the US CF Patient Registry showed that the
projected median survival of children born and diagnosed with
CF in 2010 is now projected to be 39 years overall, assuming
that mortality remains at current levels. However, if the current
rates of improvement continue, this projected survival increases
to more than 50 years. There will be a greater need for
clinicians to provide care for a growing adult population (Ann
Intern Med 2014; 161: 233–241).
NTM prevalence may be influenced by environmental
factors. Comparing US CF Patient Registry data with climactic
data suggests that higher saturated vapor pressure was
associated with an increased risk for NTM in CF sputum
cultures. However, NTM screening practices varied greatly by
state, prompting a call for routine screening for NTM in CF
patients (Am J Respir Crit Care Med 2014; 190: 581–586).
Impaired mucus detachment disrupts mucociliary transport
in piglet model of cystic fibrosis. Employing a novel method of
observing mucus transport in submerged airways, Hoegger et
al. demonstrated that mucus strands secreted from submucosal
glands remained tethered to gland ducts, an effect related to
inhibited anion secretion. Tethering of the mucus strands
adversely affects mucociliary clearance, even with a normal
ciliary fluid depth. This may offer new treatment targets for
early CF lung disease (Science 2014; 345: 818–822).
Novel X-ray imaging technique allows for study of airway
surface liquid (ASL) in vivo. Previous analyses of the ASL
using confocal microscopy were limited to the study of
epithelial cell culture only. This development represents a
non-invasive approach to ASL depth in vivo measurement,
which could be used for longitudinal, biologically-relevant
studies of new CF therapies (Am J Respir Crit Care Med 2014;
190: 469–471).
Events
28th North American Cystic Fibrosis Conference, October
7–10, 2015, Phoenix, Arizona.
ECFS 12th Basic Science Conference, March 25-28, 2015,
Albufeira, Portugal.
ECFS 38th European CF Conference, June 10–13, 2015,
Brussels, Belgium.http://dx.doi.org/10.1016/j.jcf.2014.09.010People
Discovery of the CF gene
The discovery of the CF gene in 1989 — the single most
important discovery in CF research — was the result of
international research collaboration. This year we celebrate the
25th anniversary of the landmark publication of the discovery
of the cystic fibrosis gene (Science 1989: 245: 1073–80). Even
then the feeling was that “the implications of this research are
profound” (Peter Goodfellow, Nature 1989; 341: 102–3) with
the expectation of a large clinical impact. The promise of the
gene discovery has seen success since that time with approval
of a CFTR potentiator and active study of CFTR correctors.
Whereas Francis Collins stated that getting CFTR modulators
approved would be “a milestone for all genetic disease”, and
the discovery of the CF gene is truly a milestone in CF history.
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